Machine Learning: A New Approach to Drug Discovery, Daphne Koller, Wi DS 2020

Daphne Koller, CEO and Founder at insitro delivers a Keynote presentation at WiDS Stanford University on March 2, 2020: Modern medicine has given us effective tools to treat some of the most significant and burdensome diseases. At the same time, it is becoming consistently more challenging to develop new therapeutics: clinical trial success rates hover around the midsingledigit range; the pretax R D cost to develop a new drug (once failures are incorporated) is estimated to be greater than and th